Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:47 AM
NCT ID: NCT01703702
Description: None
Frequency Threshold: 0
Time Frame: 48 hours post-injection
Study: NCT01703702
Study Brief: Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Safety Population 620 patients received florbetapir (18F) and comprise the Safety Population. None None 2 620 36 620 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Subdural haematoma NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (18.0) View
Cerebral haemorrhage NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Flushing NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (18.0) View
Asthenia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Feeling abnormal NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Malaise NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Confusional state NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (18.0) View
Hallicination, olfactory NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (18.0) View
Insomnia NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (18.0) View
Irritability NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (18.0) View
Sleep disorder NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (18.0) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (18.0) View
Abnormal faeces NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (18.0) View
Dysuria NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (18.0) View
Back pain NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (18.0) View
Myalgia NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (18.0) View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (18.0) View
Dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.0) View
Vertigo NON_SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA (18.0) View
Post procedural haematoma NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (18.0) View
Palpitations NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (18.0) View
Epistaxis NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (18.0) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.0) View